1. Home
  2. TOI vs FENC Comparison

TOI vs FENC Comparison

Compare TOI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.34

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

HOLD

Current Price

$6.88

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOI
FENC
Founded
2007
1996
Country
United States
United States
Employees
641
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
304.4M
266.4M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
TOI
FENC
Price
$3.34
$6.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$6.67
$14.50
AVG Volume (30 Days)
1.4M
143.2K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$44,642,000.00
Revenue This Year
$30.15
$65.12
Revenue Next Year
$25.77
$41.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$5.65
52 Week High
$4.88
$9.92

Technical Indicators

Market Signals
Indicator
TOI
FENC
Relative Strength Index (RSI) 53.72 53.35
Support Level $2.96 $5.65
Resistance Level $3.74 $8.09
Average True Range (ATR) 0.19 0.36
MACD -0.01 0.12
Stochastic Oscillator 52.04 85.91

Price Performance

Historical Comparison
TOI
FENC

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: